From Dire Wolf Tech to Living Species: How Colossal’s Tools Support Red Wolves, Quolls, Frogs, and More

The technologies developed to create functionally de-extinct dire wolves weren’t designed just for headlines. They were designed to support conservation work for living species. Both before and after the dire wolf announcement, Colossal reports that the same de-extinction technologies helped four critically endangered red “ghost” wolves be born, created cell lines capable of resisting deadly cane toad toxin, and produced a vaccine saving young elephants from a lethal virus. The conservation applications are accelerating, and the species benefiting span continents and taxonomies.

Breaking the Red Wolf Genetic Bottleneck

The American red wolf is the world’s most endangered canid. Very few exist in the wild, and roughly 300 under managed care descend from just 12 founder individuals. This extreme genetic bottleneck leaves the entire population vulnerable to disease, inbreeding, and extinction. Traditional conservation approaches can struggle to solve this kind of underlying genetic diversity problem on their own.

Colossal reports that the four red “ghost” wolves were born carrying ancestral red wolf DNA from genetic lineages that were previously underrepresented in today’s population, helping address a longstanding genetic bottleneck. These canids from the American Gulf Coast carry 69-72% red wolf ancestry and the highest ghost lineage content ever recovered. Named Neka Kayda (“Ghost Daughter”), Ash, Blaze, and Cinder, they could increase the number of founding lineages by 25%.

The Gulf Coast Canine Project, working with partners including the Karankawa Tribe of Texas, is using this genetic rescue to secure the red wolf’s future.

Engineering Resistance: The Northern Quoll Solution

Australia’s northern quoll faces an ecological disaster. This carnivorous marsupial has declined 75% due to invasive cane toads introduced in 1935. The toads’ lethal bufotoxin kills predators like quolls that evolved without exposure to such toxins.

Colossal researchers discovered something remarkable: mammals and snakes in South America that co-evolved with cane toads possess natural resistance through a single nucleotide change (one letter in three and a half billion base pairs) that, as described in a public interview, can confer roughly 6,000-fold resistance to the toxin. Working with the University of Melbourne, Colossal has generated northern quoll induced pluripotent stem cell (iPSC) lines, representing a major step toward producing toxin-resistant quolls.

“We need northern quolls to have a balanced ecosystem in mainland Australia,” explains Professor Andrew Pask. “By using Colossal’s technology we’re giving our conservation partners a fighting chance of succeeding in restoring that balance.” Initial trials in the fat-tailed dunnart, a model species for the thylacine, successfully engineered cells that can consume cane toad tissue with zero effect.

Saving Amphibians from the Deadliest Pandemic in Vertebrate History

Chytridiomycosis (Chytrid) has driven the extinction of nearly 100 amphibian species and imperiled more than 500 others, making it the most devastating disease threat ever recorded in vertebrates. The Colossal Foundation committed $3 million to fund a radical solution: engineering innate genetic immunity by looking to nature’s answer in the unique immune system of alpacas.

Through nanobody engineering, antimicrobial peptide screening, and transgene delivery in amphibian models, researchers are creating the first comprehensive strategy to confer immunity against chytrid infections. An alpaca has been immunized against chytrid to generate a library of powerful nanobodies, and new cane toad cell lines have been derived for amphibian-specific expression studies.

“Helping to stop the spread of chytrid isn’t optional,” says Dr. Andrew Pask. “We have to give frogs a fighting chance and ensure they remain a vital part of our planet’s biodiversity for generations to come. This will be a game-changer for amphibian conservation.”

The First mRNA Vaccine Saving Elephants

Elephant endotheliotropic herpesvirus (EEHV) is the leading cause of death among young Asian elephants in human care and a growing threat to wild populations. The Colossal Foundation helped fund and accelerate the world’s first mRNA vaccine for EEHV, partnering with Baylor College of Medicine.

In spring 2025, two vaccinated young elephants at the Cincinnati Zoo, Sanjay and Kabir, were naturally exposed to the virus. Both showed no signs of illness and recovered fully, a highly unlikely outcome without the vaccine. This watershed moment provided the first real-world evidence that the vaccine prevents severe disease and saves lives. More than 10 elephants have now been vaccinated, and five U.S. zoological institutions administer the vaccine to their herds.

“I have witnessed elephants battle EEHV time and again,” says Matt James, Executive Director of the Colossal Foundation.””I even lost a juvenile elephant under my care. To be able to get a vaccine into the world that can stop that sort of senseless loss means everything to me.”

Finding Lost Species and Building Global Infrastructure

The Victorian grassland earless dragon, unseen since 1969 and believed extinct, was rediscovered in 2023. The Colossal Foundation provided immediate funding to Zoos Victoria, enabling rapid collection of 39 animals, establishment of a conservation breeding program, retrofitting of a specialized nursery, and genome sequencing, which helped accelerate the species’ recovery. To date, 81 neonates have successfully hatched in the first two breeding seasons.

For the tooth-billed pigeon, one of the dodo’s closest living relatives with fewer than 100 individuals remaining, Colossal developed an AI-powered bioacoustics tool detecting the bird’s unique call with 95% accuracy using less than five minutes of training audio from the 1980s. This open-source algorithm has been shared with conservationists worldwide for locating other lost or elusive bird species.

The vaquita, the most endangered cetacean with only a handful remaining, benefits from Colossal’s support of Pronatura Noroeste. Through training, GPS systems, drones, and direct involvement in monitoring expeditions, local youth and women in San Felipe are now leading efforts to track and protect the last vaquitas.

The BioVault: Insurance Against Extinction

Extinction accelerates faster than conservation interventions can arrive for thousands of species. The Colossal BioVault will be the world’s largest distributed biobanking initiative, designed to protect the primary materials needed to prevent extinction.

Unlike traditional centralized biobanks, the BioVault is intentionally distributed, storing cell lines within countries where species live. This genetic repository supports future restoration projects, fertility research, and genetic rescue efforts. The Colossal 100, a priority list of the world’s most endangered vertebrates, guides biobanking and genome sequencing efforts.

Colossal’s 2025 acquisition of Viagen Pets & Equine dramatically expanded this capacity. Viagen has cloned 15 species including world-first breakthroughs like the black-footed ferret and Przewalski’s horse, achieving 80% cloning success rates far beyond the global average of approximately 2%. More than 40 species are now biobanked, including 22 threatened or endangered species.

Open Science, Open Tools

The Colossal Foundation builds high-quality reference genomes for endangered species worldwide and open-sources them to the conservation community. These genomes function as definitive genetic maps researchers use to track population health, identify lost diversity, spot harmful mutations before they spread, and guide recovery efforts.

The Foundation donated $1.5 million to support the University of Melbourne’s Australian avian conservation genomics work, dramatically expanding high-quality genomes across the avian tree of life. With one in eight bird species at risk of extinction, this genomics toolkit supports threatened birds globally.

For the pink pigeon—brought back from fewer than 10 individuals in the 1980s to over 400 today but suffering from severe genetic diversity loss—Colossal partners are conducting groundbreaking research. Early genome sequencing revealed lost variants linked to immunity and fertility, with 1,550 blood samples archived and nine whole genomes sequenced from historic samples.

Working with BioRescue Consortium on the functionally extinct northern white rhino, Colossal is deploying advanced assisted reproductive technologies. With only two females remaining, the collaboration uses DNA from museum specimens to create embryos that may restore lost genetic diversity.

From Lab to Field

“The same technologies that created the dire wolf can directly help save a variety of other endangered animals,” notes Dr. Christopher Mason, Colossal scientific advisor. “This is an extraordinary technological leap for both science and conservation.”

The conservation benefit wasn’t theoretical. It was immediate. “I have dedicated my career to protecting and recovering species that may be down to their last few individuals,” said Barney Long, senior director of conservation strategies for Re:wild. “For some of them, protecting their remaining habitat will not be enough to allow them to recover. We are at the point where we need to do something dramatically innovative. The possibilities that Colossal’s technology opens up for critically endangered species and ecosystems is game-changing.”

These tools, including genome sequencing, multiplex gene editing, AI-powered monitoring, biobanking, disease mitigation, and assisted reproduction, form an integrated conservation toolkit addressing biodiversity loss at scale. And critically, the technologies continue improving as they’re applied across diverse species and ecosystems, creating a feedback loop where each application advances the entire field.